Skip to main content

Table 1 Clinical characteristics of study participants

From: Vascular dysfunction and body mass index in African adults with HIV

Variables

Underweight (n = 38)

Normal weight (n = 43)

Overweight (n = 10)

P

Age, years*

41 (43–40)

40 (43–33)

40 (42–30)

0.56 K

Sex, Female

16 (42%)

27 (63%)

9 (90%)

0.01C

Alcohol use, yes

21 (55%)

22 (51%)

2 (20%)

0.13C

Tobacco use, yes

11 (29%)

4 (9%)

1 (10%)

0.06C

Height, cm

167.2 (174–158)

164.2 (169–159)

161.1 (168.4–156.5)

0.13 K

Waist hip ratio

0.81(0.41–1.14)

0.79 (0.56–0.97)

0.85 (0.75–1.02)

0.90 K

Central systolic blood pressure, mmHg

105 (114–101)

108 (120–100)

129 (137–121)

0.51 K

Central diastolic blood pressure, mmHg

76 (85–73)

77 (86–70)

84.5 (102–67)

0.47 K

Mean arterial pressure, mmHg

97 (100–89)

92 (104–81)

93 (100–89)

0.45 K

Carotid-radial augmentation index, crAIX

14.5 (39.7–8.9)

22.35 (42.5–11.35)

22.9 (38.3–6.3)

0.44 K

Carotid-femoral augmentation index, cfAIX

24.2 (33.98–5.9)

18.5 (33.6–8.9)

24.8 (42.1–13.2)

0.42 K

Carotid-femoral pulse wave velocity, m/s

7.9 (9.3–5.9)

6.9 (8.1–6.3)

7.0 (7.7–5.9)

0.36 K

Carotid-radial pulse wave velocity, m/s

10.0 (13.0–9.0)

10.0(11.2–8.4)

9.5 (11.6–8.0)

0.22 K

Pulse pressure, mmHg

37.5 (43–34)

37.8 (48.5–33.6)

41 (42–36)

0.51 K

  1. *Medians and interquartile ranges and frequency. The Kruskal Wallis test used to compare continuous values across groups (K = kruskal walis), Chi square test used to compare categorical variables(C-Chi square). HIV, human immunodeficiency virus; PWH, persons with HIV; BMI, body mass index